[{"Assets_0_FY_USD":173707166.0,"CommonStockSharesOutstanding_0_FY_shares":74062370.0,"EarningsPerShareBasic_1_FY_USD":-0.35,"EarningsPerShareBasic_4_FY_USD":-1.01,"EarningsPerShareDiluted_1_FY_USD":-0.36,"EarningsPerShareDiluted_4_FY_USD":-1.01,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-62555052.0,"NetIncomeLoss_4_FY_USD":-73740339.0,"StockholdersEquity_0_FY_USD":123282151.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":73214766.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":73214766.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170315"}]